The International Advisory Committee on Clinical Trials in Multiple Sclerosis is a global body sponsored by ECTRIMS and the US National Multiple Sclerosis Society (NMSS). The Committee has been in existence for over 30 years and is composed of experts in clinical trials and clinical research in MS.
The Committee provides perspective and guidance in areas of interest to planning and implementation of clinical trials for new agents for the treatment of multiple sclerosis. It is well known for its work in developing the McDonald Diagnostic Criteria and the 1996 and 2013 clinical course descriptors for MS. The Committee works as a whole, in international meetings and consensus-building activities, or through subcommittees and task forces on specific topics.